Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer

by Rosane eVianna-Jorge, Rosane eVianna-Jorge, Juliana eFesta-Vasconcellos, Juliana eFesta-Vasconcellos, Sheyla Mria Torres Goulart-Citrangulo, Marcelo Sobral Leite, Marcelo Sobral Leite
Published 2013-01-01

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

by Marcelo Sobral-Leite, Esther H Lips, Hayra de Andrade Vieira-Monteiro, Letícia Carlos Giacomin, Daniely Regina Freitas-Alves, Sten Cornelissen, Lennart Mulder, Jelle Wesseling, Marjanka K Schmidt, Rosane Vianna-Jorge
Published 2017-01-01

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

by Marcelo Sobral-Leite, Izhar Salomon, Mark Opdam, Dinja T. Kruger, Karin J. Beelen, Vincent van der Noort, Ronald L. P. van Vlierberghe, Erik J. Blok, Daniele Giardiello, Joyce Sanders, Koen Van de Vijver, Hugo M. Horlings, Peter J. K. Kuppen, Sabine C. Linn, Marjanka K. Schmidt, Marleen Kok
Published 2019-08-01

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

by Marcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K.J. Hooijer, Hugo M. Horlings, Tesa M. Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J. van de Vijver, Rene Bernards, Irene L. Andrulis, Marleen Kok, Karin E. de Visser, Marjanka K. Schmidt
Published 2018-12-01